Ashley E. Glode

611 total citations
28 papers, 420 citations indexed

About

Ashley E. Glode is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Ashley E. Glode has authored 28 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Geriatrics and Gerontology. Recurrent topics in Ashley E. Glode's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Ashley E. Glode is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Ashley E. Glode collaborates with scholars based in United States. Ashley E. Glode's co-authors include Jennifer Weiss, Cindy L. O’Bryant, Wells A. Messersmith, Jennifer R. Diamond, Laurence Cooke, Hani M. Babiker, Daruka Mahadevan, Lisa Thompson, Luciano J. Costa and Ashley Miller and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics and Journal of Surgical Research.

In The Last Decade

Ashley E. Glode

27 papers receiving 411 citations

Peers

Ashley E. Glode

ONCOL

RNMI

SURGE

IMMUN

Yinhua Liu China

Risto S Cvetkovi New Zealand

Stephanie K A Blick New Zealand

Gina Wong Canada

Joanna Peng United States

Fadel Bennani Ireland

Stefanie Bertram Germany

Tingting Han China

Sen Sheng United States

Hiroo Makimoto Japan

Yinhua Liu China

Ashley E. Glode

180 ×1.0

ONCOL

94 ×1.2

96 ×1.5

RNMI

72 ×1.2

SURGE

24 ×0.5

IMMUN

Citations per year, relative to Ashley E. Glode Ashley E. Glode (= 1×) peers Yinhua Liu

Countries citing papers authored by Ashley E. Glode

Since Specialization

Citations

This map shows the geographic impact of Ashley E. Glode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley E. Glode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley E. Glode more than expected).

Fields of papers citing papers by Ashley E. Glode

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley E. Glode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley E. Glode. The network helps show where Ashley E. Glode may publish in the future.

Co-authorship network of co-authors of Ashley E. Glode

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley E. Glode. A scholar is included among the top collaborators of Ashley E. Glode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley E. Glode. Ashley E. Glode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davis, James A., et al.. (2022). Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma. Journal of Oncology Pharmacy Practice. 28(3). 686–690. 7 indexed citations

Glode, Ashley E., et al.. (2021). Immune checkpoint inhibitors: Significant advancements in non–small cell lung cancer treatment. American Journal of Health-System Pharmacy. 78(9). 769–780. 10 indexed citations

Glode, Ashley E., et al.. (2020). Evaluation of fosaprepitant-associated hypersensitivity reactions at a National Cancer Center. Journal of Oncology Pharmacy Practice. 26(6). 1369–1373. 3 indexed citations

Academia, Emmeline C., et al.. (2019). A Review of PI3K Inhibitors in B-Cell Malignancies. Journal of the Advanced Practitioner in Oncology. 10(7). 715–725. 2 indexed citations

Glode, Ashley E., et al.. (2019). Apalutamide: A new agent in the management of prostate cancer. Journal of Oncology Pharmacy Practice. 25(8). 1968–1978. 8 indexed citations

Dewberry, Lindel C., Ashley E. Glode, Tracey E. Schefter, et al.. (2018). Pilot Prehabilitation Program for Patients With Esophageal Cancer During Neoadjuvant Therapy and Surgery. Journal of Surgical Research. 235. 66–72. 32 indexed citations

Davis, S. Lindsey, Elaine T. Lam, Bradley R. Corr, et al.. (2018). Abstract A083: A phase Ib study of the combination of MLN0128 (dual TORC1/2 inhibitor) and MLN8237 (Aurora A inhibitor, alisertib) in patients with advanced solid tumors. Molecular Cancer Therapeutics. 17(1_Supplement). A083–A083. 1 indexed citations

Babiker, Hani M., Ashley E. Glode, Laurence Cooke, & Daruka Mahadevan. (2018). Ublituximab for the treatment of CD20 positive B-cell malignancies. Expert Opinion on Investigational Drugs. 27(4). 407–412. 36 indexed citations

Glode, Ashley E., et al.. (2018). Collaboration Leads to Oral Chemotherapy Education. Journal of the Advanced Practitioner in Oncology. 9(7). 755–756.

10.

Thompson, Angela, et al.. (2017). Clinical pharmacy academic career transitions: Viewpoints from the field Part 2: Understanding and balancing the distribution of effort. Currents in Pharmacy Teaching and Learning. 10(2). 128–132. 3 indexed citations

11.

Jeffres, Meghan N., et al.. (2017). Clinical pharmacy academic career transitions: Viewpoints from the field part 3: Learning when and how to say yes. Currents in Pharmacy Teaching and Learning. 10(2). 133–136. 2 indexed citations

12.

Blackmer, Allison B., et al.. (2017). Clinical pharmacy academic career transitions: Viewpoints from the fieldPart 1: Understanding feedback, evaluation, and advancement. Currents in Pharmacy Teaching and Learning. 10(2). 123–127. 2 indexed citations

13.

Glode, Ashley E., et al.. (2016). Novel Uses for Lipid-Lowering Agents. Journal of the Advanced Practitioner in Oncology. 7(2). 181–187. 8 indexed citations

14.

Glode, Ashley E., et al.. (2016). Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics. Cancer Management and Research. 8. 49–49. 45 indexed citations

15.

Glode, Ashley E., et al.. (2016). Ramucirumab: A vascular endothelial growth factor receptor-2 inhibitor with activity in several malignancies. American Journal of Health-System Pharmacy. 73(13). 957–968. 14 indexed citations

16.

Glode, Ashley E., et al.. (2015). Blinatumomab: A novel, bispecific, T-cell engaging antibody. American Journal of Health-System Pharmacy. 73(1). e6–e13. 16 indexed citations

17.

Glode, Ashley E., et al.. (2014). Olanzapine: An Antiemetic Option for Chemotherapy-Induced Nausea and Vomiting. Journal of the Advanced Practitioner in Oncology. 5(1). 24–9. 25 indexed citations

18.

Jarkowski, Anthony, et al.. (2010). Heart Failure Caused by Molecularly Targeted Therapies for Cancer. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(1). 62–75. 2 indexed citations

19.

Miller, Ashley, et al.. (2010). Efficacy and Safety of Ciprofloxacin for Prophylaxis of Polyomavirus BK Virus–Associated Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Biology of Blood and Marrow Transplantation. 17(8). 1176–1181. 55 indexed citations

20.

Glode, Ashley E. & Anthony Jarkowski. (2009). Bendamustine: A New Treatment Option for Chronic Lymphocytic Leukemia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(11). 1375–1384. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact